Robert Califf
| Robert Califf | |
|---|---|
 |
|
| Commissioner of Food and Drugs | |
|
In office February 22, 2016 – January 20, 2017 |
|
| President | Barack Obama |
| Preceded by | Stephen Ostroff (Acting) |
| Succeeded by | Stephen Ostroff (Acting) |
| Personal details | |
| Born | 1951 (age 65–66) Anderson, South Carolina, U.S. |
| Political party | Democratic |
| Alma mater | Duke University |
Robert Califf is an American cardiologist and the former Commissioner of the Food and Drug Administration. He was nominated to be commissioner in September 2015 by President Barack Obama and he was confirmed by the U.S. Senate in February 2016. Prior to becoming commissioner he had served as the Deputy Commissioner of the United States Food and Drug Administration's Office of Medical Products and Tobacco since January 2015.
Califf was born in 1951 in Anderson, South Carolina. He attended high school in Columbia, South Carolina where he was a member of the 1969 AAAA South Carolina Championship basketball team. He attended Duke University, graduating in 1973 summa cum laude, and is a member of Phi Beta Kappa. In 1978, he graduated from the Duke University School of Medicine in Durham, North Carolina, and was inducted into the Alpha Omega Alpha medical honor society. He left North Carolina only for an internal medicine residency at the University of California, San Francisco, and returned in 1980 to Duke to complete a fellowship in cardiology. He is board-certified in internal medicine (1984) and cardiology (1986), and a Master of the American College of Cardiology (2006).
Califf was granted tenure as professor of cardiology at Duke University School of Medicine. He was the founding director of the Duke Clinical Research Institute, which is considered "the world’s largest academic research organization" with 1000 employees and an annual budget of $320 million, 50-60% of which is funded from industry.
Califf has led many clinical cardiology research studies, health outcomes research, health care quality, and translational research, which seeks to ensure that advances in science translate into medical care. He was a lead investigator in clinical trials testing the efficacy of the cholesterol-lowering drug combination ezetimibe/simvastatin.
...
Wikipedia